Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Polypeptide >  GLUCAGON HYDROCHLORIDE(HUMAN)

GLUCAGON HYDROCHLORIDE(HUMAN)

Basic information Safety Supplier Related

GLUCAGON HYDROCHLORIDE(HUMAN) Basic information

Product Name:
GLUCAGON HYDROCHLORIDE(HUMAN)
Synonyms:
  • Hyperglycemic-glycogenolytic factor
  • l-l-alpha-aspartyl-l-seryl-l-arginyl-l-arginyl-l-alanyl-l-glutaminyl-l-alpha-a
  • spartyl-l-phenylalanyl-l-valyl-l-glutaminyl-l-tryptophyl-l-leucyl-l-methionyl-
  • threonyl-l-seryl-l-alpha-aspartyl-l-tyrosyl-l-seryl-l-lysyl-l-tyrosyl-l-leucy
  • GLUCAGON HYDROCHLORIDE(HUMAN)
  • glucagon[pig]
  • glukagonnovo
  • his-ser-glu(nh2)-gly-thr-phe-thr-ser-asp-tyr-ser-lys-tyr-leu-asp-ser-arg-arg-a
CAS:
9007-92-5
MF:
C153H226ClN43O49S
MW:
3519.21
EINECS:
232-708-2
Product Categories:
  • Amino Acids & Derivatives
  • Peptides
Mol File:
9007-92-5.mol
More
Less

GLUCAGON HYDROCHLORIDE(HUMAN) Chemical Properties

storage temp. 
2-8°C
solubility 
Methanol (Very Slightly, Heated, Sonicated), Water
form 
powder
More
Less

Safety Information

Safety Statements 
22-24/25
WGK Germany 
3
RTECS 
LZ3980000
3-10-21
Hazardous Substances Data
9007-92-5(Hazardous Substances Data)
More
Less

GLUCAGON HYDROCHLORIDE(HUMAN) Usage And Synthesis

Description

GlucaGon, a recombinant DNA product, was developed as a nasal formulation of glucagon for the treatment of insulin-induced hypoglycemia. Glucagon is widely used by insulin dependent diabetic patients as an emergency treatment for severe hypoglycemic reactions. Use of genetically engineered glucagon by both intranasal and intramuscular methods has a similar effect on hepatic glucose production rate as natural glucagon from pancreatic extraction.

Originator

Novo-Nordisk (Denmark)

Uses

Glucagon is a hormone secreted by the pancreas that raises blood glucose levels. Glucagon is released by the pancreas when blood sugar (glucose) levels fall too low. Glucagon causes the liver to convert stored glycogen into glucose thus increasing glucose levels and having the opposite effect of insulin.

Manufacturing Process

The process comprises treating pancreatic gland material having hyperglycemic activity in aqueous solution at pH 3-4 with 3-4 volumes of acetone to precipitate the hyperglycemic activity material, separating the precipitate and dializing the precipitate to remove inorganic salts and dialyzable low molecular weight impurities, and crystallizing the undialyzed hyperglycemic activity material from aqueous glycine buffer.

brand name

GlucaGen

Therapeutic Function

Antidiabetic

GLUCAGON HYDROCHLORIDE(HUMAN)Supplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Sinopharm Chemical Reagent Co,Ltd.
Tel
86-21-63210123
Email
sj_scrc@sinopharm.com
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Email
waley188@sohu.com
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-6206333 18521732826;
Email
market@aladdin-e.com